Results 261 to 270 of about 3,310,854 (363)
Clocking Injustice: Racial Disparities in Specialty Wait Times
ABSTRACT Objective Timely access to care is associated with improved morbidity, mortality, and quality of life, making disparate access to specialty care a potential contributor to racial inequities in health outcomes. In this nationwide analysis, we quantified specialty care waits by race and ethnicity and identified potential drivers of observed ...
Daniel A. Asfaw+3 more
wiley +1 more source
Mycophenolate mofetil (MMF) demonstrates superior efficacy and tolerability compared to azathioprine (AZA) in treatment‐naïve autoimmune hepatitis (AIH) patients. Meta‐analysis of five studies reveals higher complete biochemical response rates, increased Corticosteroid withdrawal rate, and fewer gastrointestinal side effects with MMF.
Muhammad Tayyab Anwar+12 more
wiley +1 more source
Periorbital skin hypopigmentation associated with the use of topical glaucoma medications. [PDF]
Karimaghaei S, Yee J, Elhusseiny AM.
europepmc +1 more source
Dermatological Effects of Different Keratolytic Agents on Acne Vulgaris
Essa Ajmi Alodeani
openalex +1 more source
SQSTM1/p62 Orchestrates Skin Aging via USP7 Degradation
p62 exhibits diminished expression in aging skin and senescent cells. p62 serves to inhibit the accumulation of USP7 during senescence induction. The Tyr‐67 residue within the PB1 domain or Gln‐418 within the UBA domain of p62 forms a hydrogen bond with Ala‐993 of the Ubl5 domain of USP7.
Liu Chen+10 more
wiley +1 more source
Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report. [PDF]
Morrissette K+3 more
europepmc +1 more source
DERMATOLOGICAL ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS: EXPERIENCE FROM A TERTIARY CENTRE
Parvaiz Anwar Rather+5 more
openalex +1 more source
Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott+3 more
wiley +1 more source
Safety of dermatologic agents in pregnancy.
Sushil Pande, Vidya Kharkar
openaire +1 more source